ABCD of hypertension treatment: Ask about lithium, too

BMJ

Volumn 342, Issue 7805, 2011, Pages

  Smith, Tom G ^a  

^a ST CHARLES HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LITHIUM SALT; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM SPARING DIURETIC AGENT; LITHIUM DERIVATIVE;

BIPOLAR DISORDER; DEHYDRATION; DIARRHEA; DRUG BLOOD LEVEL; DRUG EXCRETION; FATALITY; GLOMERULUS FILTRATION RATE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; LETTER; PRIORITY JOURNAL; SODIUM DEPLETION; VOMITING; DRUG INTERACTION; NOTE;

ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DRUG INTERACTIONS; HUMANS; HYPERTENSION; LITHIUM COMPOUNDS;

EID: 79955659679     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d2718     Document Type: Letter

References (3)

1. Ritter JM. Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in hypertension. BMJ 2011;342:d1673. (7 April.)
2. National Institute for Health and Clinical Excellence. The management of bipolar disorder in adults, children and adolescents in primary and secondary care. CG38. 2006. http://guidance.nice.org.uk/CG38.
3. Juurlink DN, Mamdani MM, Kopp A, Rochon PA, Shulman KI, Redelmeier DA. Drug-induced lithium toxicity in the elderly: a population-based study. J Am Geriatr Soc 2004;52:794-8. (Pubitemid 38596502)